Evidence map›Paper›PMID 29056665›Full record

ReviewVeterinary sciences2017

Review on Usage of Vancomycin in Livestock and Humans: Maintaining Its Efficacy, Prevention of Resistance and Alternative Therapy.

Panditharathnalage Nishantha Kumara Wijesekara, Wikum Widuranga Kumbukgolla, Jayaweera Arachchige Asela Sampath Jayaweera, Diwan Rawat

Open access · goldAbstract readReview
In one paragraph

Review in Veterinary sciences, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 67 citations in OpenAlex.

  1. Article
  2. Genotypic Profiling of Virulence and Antibiotic Resistance Genes ofInternational journal of microbiology · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. The Synthetic Peptide LyeTx I mn∆K, Derived fromAntibiotics (Basel, Switzerland) · 2024
    Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Resistance towards Critically Important Antimicrobials amongAntibiotics (Basel, Switzerland) · 2022
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Panditharathnalage Nishantha Kumara WijesekaraHuman Recourse Department, University Grants Commission, 20, Ward Place, Colombo 07 10000, Sri Lanka. nkwijesekara@gmail.com.
Wikum Widuranga KumbukgollaDepartment of Biochemistry, Faculty of Medicine and Allied Sciences, Rajarata University Mihintale, Mihintale 50008, Sri Lanka. kumbukgolla@yahoo.com.
Jayaweera Arachchige Asela Sampath JayaweeraDepartment of Microbiology, Faculty of Medicine and Allied Sciences, Rajarata University Mihintale, Mihintale 50008, Sri Lanka. jaasjayaweera@med.rjt.ac.lk.
Diwan RawatDepartment of Chemistry, University of Delhi, Delhi 110007, India. dsrawat@chemistry.du.ac.in.
Rajarata University of Sri Lanka · LKUniversity Grants Commission Sri Lanka · LKUniversity of Delhi · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vancomycin is one of the "last-line" classes of antibiotics used in the treatment of life-threatening infections caused by Gram-positive bacteria. Even though vancomycin was discovered in the 1950s, it was widely used after the 1980s for the treatment of infections caused by methicillin-resistant

Indexed as

alternativesbroad viewrational usevancomycinveterinary use at a glance

Identifiers

PMID29056665
PMCPMC5606620
OpenAlexW2563294409

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.